Trinidad and Tobago Fashion Company

Boyne Capital Makes New Platform Investment in ProFusion Industries

Retrieved on: 
Monday, October 30, 2023
OH, EBITDA, Trinidad and Tobago Fashion Company, Certification, Engineering, Unjust enrichment, Growth, Transport, Mat, The Company, Fund, Culture, VSC, Investment, Fine chemical, Asset management

MIAMI, Oct. 30, 2023 /PRNewswire/ -- Boyne Capital ("Boyne") is pleased to announce that one of its affiliates has invested in ProFusion Industries ("ProFusion" or the "Company"), a designer, engineer and manufacturer of polymer-based film and sheet products for a variety of end markets.

Key Points: 
  • MIAMI, Oct. 30, 2023 /PRNewswire/ -- Boyne Capital ("Boyne") is pleased to announce that one of its affiliates has invested in ProFusion Industries ("ProFusion" or the "Company"), a designer, engineer and manufacturer of polymer-based film and sheet products for a variety of end markets.
  • Headquartered in Fairlawn, OH, ProFusion manufactures products that serve diversified end markets, including hospitality, transportation, military, general matting and industrial.
  • Derek McDowell , Managing Partner at Boyne Capital, said, "We are excited to partner with ProFusion given its market leading position and capabilities.
  • Roman Krislav , Managing Director at Boyne Capital, stated, "We are thrilled to partner with the team at ProFusion.

WILDBRAIN PROMOTES JOSH SCHERBA TO PRESIDENT AND CEO

Retrieved on: 
Tuesday, May 9, 2023
Well, WildBrain, DreamWorks, Claire's, Apple TV, 20th Century Studios, BBC, Marketing, House of Cool, Melissa Peterman, The Walt Disney Company, Josh, IP, History, Shcherba, Gap, LEGO, Mattel, Schonfeld Strategic Advisors, TSX, Growth, SEGA, Development, Netflix, House, Trinidad and Tobago Fashion Company, Fielding, Management, Amazon

TORONTO, May 9, 2023 /PRNewswire/ - WildBrain Ltd. ("WildBrain" or the "Company") (TSX: WILD), a global leader in kids' and family entertainment, has promoted Josh Scherba to the role of President and Chief Executive Officer.

Key Points: 
  • TORONTO, May 9, 2023 /PRNewswire/ - WildBrain Ltd. ("WildBrain" or the "Company") (TSX: WILD), a global leader in kids' and family entertainment, has promoted Josh Scherba to the role of President and Chief Executive Officer.
  • Under the Company's succession plan, Scherba replaces Eric Ellenbogen who has stepped down as CEO and Vice Chair.
  • We're confident Josh has the right combination of strategic vision, deep industry expertise and operational insights to take WildBrain forward into this next phase of growth."
  • Josh Scherba stated: "It's an incredibly exciting time at WildBrain, and I'm honoured that our board has put their support behind me to lead the Company.

Bee Vectoring Technologies Announces Fiscal Year 2022 Financial Results and 2023 Business Outlook

Retrieved on: 
Tuesday, January 31, 2023
Weather, Clonostachys, PMRA, CVE, CSE, Soil, MD, FINANCIAL, Agriculture, Partnership, Intellectual property, Trinidad and Tobago Fashion Company, Soybean, Growth, Pest Management Regulatory Agency, SEDAR, Pacific Northwest, Hyco International Inc, Letter, BVT, Pleasure, Controlled-environment agriculture, Fine chemical

Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - January 31, 2023) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") today released a letter to shareholders from Chief Executive Officer Ashish Malik announcing the financial results for the fourth quarter and fiscal year ended September 30, 2022.

Key Points: 
  • Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - January 31, 2023) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") today released a letter to shareholders from Chief Executive Officer Ashish Malik announcing the financial results for the fourth quarter and fiscal year ended September 30, 2022.
  • The shareholder letter is as follows:
    It is with pleasure that I present to you BVT's 2022 fiscal year-end results, along with successful key milestones achieved as well as the outlook for BVT's future.
  • The BVT team has planned and worked diligently to build a solid foundation for growth and are excited for 2023 and beyond.
  • Thank you for your support and we look forward to sharing further updates with you as the business continues to progress.

Keurig Dr Pepper Appoints Chief Financial Officer

Retrieved on: 
Monday, October 24, 2022
CFO, Growth, Softline, Strategic planning, NASDAQ, KDP, Piyadasi, Company, Information technology, Financial management, CPG, Walmart, Leadership, Multinational, PepsiCo, Fashion merchandising, Trinidad and Tobago Fashion Company, Solution, Sudhanshu Sharma, Management, Finance, BURLINGTON, Flexport, Cipla

BURLINGTON, Mass.andFRISCO,Texas, Oct. 24, 2022 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ: KDP) today announced the appointment of Sudhanshu Priyadarshi to the position of Chief Financial Officer, effective Nov. 14, 2022.

Key Points: 
  • BURLINGTON, Mass.andFRISCO,Texas, Oct. 24, 2022 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ: KDP) today announced the appointment of Sudhanshu Priyadarshi to the position of Chief Financial Officer, effective Nov. 14, 2022.
  • He will report to Chief Executive Officer Ozan Dokmecioglu and lead the Company's Finance and Information Technology organizations.
  • "Sudhanshu's impressive financial management experience at leading companies, combined with his strategic and operational savvy, makes him the ideal executive for this critical role," said Dokmecioglu.
  • Priyadarshi started his career at PepsiCo, where he spent 14 years in financial and corporate strategy roles, including as CFO of Global R&D & PepsiCo Global Nutrition Platforms.

IBM, ABBV, & TWTR Class Actions: Bronstein, Gewirtz & Grossman, LLC, A Leading Class Action Firm Reminds Shareholders to Actively Participate

Retrieved on: 
Tuesday, May 31, 2022
Segment, Trinidad and Tobago Fashion Company, Tofacitinib, Company, Defendant, News, AbbVie, Complaint, FDA, JAK, Lists of schools in England, Musk, Court, IBM, CAMS, Safety, Twitter, LLC, Growth, NYSE, GLOBE, Marketing, Upadacitinib

NEW YORK, May 31, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies.

Key Points: 
  • NEW YORK, May 31, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies.
  • You can review a copy of the Complaints by visiting the links belowor you may contact Peretz Bronstein, Esq.
  • or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at212-697-6484.
  • The complaint alleges that, throughout the Class Period, the Defendants made materially false and/or misleading statements, about the companys business and operations.

IBM, ABBV, & TWTR Class Actions: Bronstein, Gewirtz & Grossman, LLC, A Leading Class Action Firm Reminds Shareholders to Actively Participate

Retrieved on: 
Monday, May 23, 2022
Segment, Trinidad and Tobago Fashion Company, Tofacitinib, Company, Defendant, News, AbbVie, Complaint, FDA, JAK, Lists of schools in England, Musk, Court, IBM, CAMS, Safety, Twitter, LLC, Growth, NYSE, GLOBE, Marketing, Upadacitinib

NEW YORK, May 23, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies.

Key Points: 
  • NEW YORK, May 23, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies.
  • You can review a copy of the Complaints by visiting the links belowor you may contact Peretz Bronstein, Esq.
  • or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at212-697-6484.
  • The complaint alleges that, throughout the Class Period, the Defendants made materially false and/or misleading statements, about the companys business and operations.

IBM, ABBV, & TWTR Class Actions: Bronstein, Gewirtz & Grossman, LLC, A Top Class Action Firm Reminds Shareholders to Actively Participate

Retrieved on: 
Friday, May 13, 2022
Segment, Trinidad and Tobago Fashion Company, Tofacitinib, Company, Defendant, News, AbbVie, Complaint, FDA, JAK, Lists of schools in England, Musk, Court, IBM, CAMS, Safety, Twitter, LLC, Growth, NYSE, GLOBE, Marketing, Upadacitinib

NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies.

Key Points: 
  • NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies.
  • You can review a copy of the Complaints by visiting the links belowor you may contact Peretz Bronstein, Esq.
  • or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at212-697-6484.
  • The complaint alleges that, throughout the Class Period, the Defendants made materially false and/or misleading statements, about the companys business and operations.

Goodness Growth Holdings Announces Second Quarter 2021 Financial Results

Retrieved on: 
Friday, August 13, 2021
Tax, EDGAR, EBITDA, Venture, Kashrut, SEDAR, News, Achievement, Company, Science, Biomass, Event, Research, Earnings before interest, taxes, depreciation and amortization, Cannabis, Depreciation, Board, Growth, Plant, Board of directors, Horizon, Interest, ID, Trinidad and Tobago Fashion Company, Investor relations, Security (finance), Bank, Renewable energy

Total operating expenses in the second quarter were $10.2 million, a reduction of $5.5 million as compared to $15.6 million in the second quarter of 2020.

Key Points: 
  • Total operating expenses in the second quarter were $10.2 million, a reduction of $5.5 million as compared to $15.6 million in the second quarter of 2020.
  • Goodness Growth management will host a conference call with research analysts today, Friday, August 13, 2021 at 8:00 a.m.
  • ET (7:00 a.m. CT) to discuss its financial results for its second quarter ended June 30, 2021.
  • Additional information relating to the Company's second quarter 2021 results will be available on EDGAR and SEDAR later today.

Crescita Reports Second Quarter 2021 Results and Provides Corporate Update

Retrieved on: 
Wednesday, August 11, 2021
Science, Other Science, Research, Finance, General Health, Health, Professional Services, Other Health, Risk management, Gel, Company, Skin, Joint Medical Service (Germany), OTC, Heart, Forward-looking statement, AIF, COVID-19, Risk, Goal, Ageing, CTX, TSX, Trinidad and Tobago Fashion Company, Marketing, Growth, MD, Mask, Cosmetics

Crescita (TSX: CTX and OTC US: CRRTF) is a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D and manufacturing capabilities.

Key Points: 
  • Crescita (TSX: CTX and OTC US: CRRTF) is a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D and manufacturing capabilities.
  • The Company offers a portfolio of high-quality, science-based non-prescription skincare products and early to commercial stage prescription products.
  • The portfolio is designed to address preventive care to combating the first signs of aging, as well as all primary aesthetic skin concerns.
  • Pliaglis is a topical local anesthetic cream that provides safe and effective local dermal analgesia on intact skin prior to superficial dermatological procedures.